Small Cap 60: Valeo Is A Commercial Stage, Revenue Generating Company With Q3 Revenue of $5.7M

Small Cap 60: Valeo Is A Commercial Stage, Revenue Generating Company With Q3 Revenue of $5.7M

Valeo Pharma Valeo Pharma is a pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respirology, Neurodegenerative Diseases, Oncology and other specialty products. Headquartered in Kirkland, Quebec , Valeo Pharma has the full capability and complete infrastructure to register and properly manage its growing product portfolio through all stages of commercialization. For more information, please visit www.valeopharma.com and follow us on LinkedIn and Twitter.

BioSyent Inc.blood clotCSE

Post a Comment

0 Comments